Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besifloxacin Prophylaxis in Cataract Surgery
NCT04542759Phase 1Completed
- Sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana
- Start
- Jan 2017
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Besifloxacin ophthalmic suspension vehicle in endophthalmitis (2 arms), sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. Primary endpoint: Percentage of positive cultures at 3 days. Started Jan 2017; status: completed.
02
Drugs
Besifloxacin ophthalmic suspension vehicle
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT04542759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542759.